Zhijian L. Yu
Huazhong University Of Science And Technology Union Shenzhen Hospital And The 6th Affiliated Hospital Of Shenzhen University
Shenzhen, 518082, China
Shenzhen, 518082, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Unveiling the antibacterial activity and mechanisms of BMS-303141 against Staphylococcus aureus.
Journal: BMC microbiology
Published: March 10, 2026
Drug repurposing: antimicrobial and antibiofilm effects of MLS0315771 against Gram-positive bacteria.
Journal: BMC microbiology
Published: January 16, 2026
Dingxin Recipe III resolves atherosclerotic inflammation via revitalizing Regulatory T cell lineage fidelity associated with fatty acid oxidation metabolic reprogramming.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 13, 2026
Repurposing GSK2018682 Confers Dual Antibacterial and Antibiofilm Activity against Staphylococcus aureus.
Journal: ACS infectious diseases
Published: January 12, 2026
Antibacterial and anti-virulence activity of the repurposed agent SX-682 against Staphylococcus aureus.
Journal: BMC microbiology
Published: January 06, 2026
Chinese guidelines on comprehensive assessment of clinical practice in hematopoietic stem cell transplantation Δ.
Journal: Journal of cancer research and therapeutics
Published: December 02, 2025
The adaptive growth and mechanisms of Klebsiella pneumoniae under sucrose and glucose exposure.
Journal: Microbiology spectrum
Published: October 16, 2025
Repurposing Azeliragon as a novel antibacterial agent against methicillin-resistant Staphylococcus aureus via combined membrane phospholipids and cell wall targeting.
Journal: Communications biology
Published: October 16, 2025
Last Updated: 09/26/2026